Request Sample Inquiry
Point Of Care Molecular Diagnostics Market

Point Of Care Molecular Diagnostics Market

Point Of Care Molecular Diagnostics Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

148

Base Year:

2022

Date

Sep - 2023

Format:

PDF XLS PPT

Report Code:

VMR-

Segments Covered
  • By Technology By Technology Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH), DNA Sequencing, Microarrays, Other Technologies
  • By Application Type By Application Type Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, Other Applications
  • By End-Use By End-Use Decentralized Labs, Hospitals, Home-care, Assisted Living Healthcare Facilities, Research Institutes, Other End Uses
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 4.1 Billion
Revenue 2030Revenue 2030: USD 8.2 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 9.1%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Point Of Care Molecular Diagnostics Market - Segment Analysis
    1. Overview
    2. Global Point Of Care Molecular Diagnostics Market, 2016 - 2028 (USD Million)
    3. Global Point Of Care Molecular Diagnostics Market - by Technology
      1. By Polymerase Chain Reaction (PCR)
      2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
      4. By DNA Sequencing
      5. By Microarrays
      6. By Other Technologies
    4. Global Point Of Care Molecular Diagnostics Market - by Application Type
      1. By Infectious Diseases
      2. By Oncology
      3. By Hematology
      4. By Prenatal Testing
      5. By Endocrinology
      6. By Other Applications
    5. Global Point Of Care Molecular Diagnostics Market - by End-Use
      1. By Decentralized Labs
      2. By Hospitals
      3. By Home-care
      4. By Assisted Living Healthcare Facilities
      5. By Research Institutes
      6. By Other End Uses
    6. Global Point Of Care Molecular Diagnostics Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Point Of Care Molecular Diagnostics Market - Segment Analysis
    1. Overview
    2. North America Point Of Care Molecular Diagnostics Market, 2016 - 2028 (USD Million)
    3. North America Point Of Care Molecular Diagnostics Market, by Technology
      1. By Polymerase Chain Reaction (PCR)
      2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
      4. By DNA Sequencing
      5. By Microarrays
      6. By Other Technologies
    4. North America Point Of Care Molecular Diagnostics Market, by Application Type
      1. By Infectious Diseases
      2. By Oncology
      3. By Hematology
      4. By Prenatal Testing
      5. By Endocrinology
      6. By Other Applications
    5. North America Point Of Care Molecular Diagnostics Market, by End-Use
      1. By Decentralized Labs
      2. By Hospitals
      3. By Home-care
      4. By Assisted Living Healthcare Facilities
      5. By Research Institutes
      6. By Other End Uses
    6. North America Point Of Care Molecular Diagnostics Market, by Country
      1. U.S.
        1. U.S. Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. U.S. Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. U.S. Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      2. Canada
        1. Canada Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. Canada Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. Canada Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      3. Mexico
        1. Mexico Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. Mexico Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. Mexico Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
  5. Europe Point Of Care Molecular Diagnostics Market - Segment Analysis
    1. Overview
    2. Europe Point Of Care Molecular Diagnostics Market, 2016 - 2028 (USD Million)
    3. Europe Point Of Care Molecular Diagnostics Market, by Technology
      1. By Polymerase Chain Reaction (PCR)
      2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
      4. By DNA Sequencing
      5. By Microarrays
      6. By Other Technologies
    4. Europe Point Of Care Molecular Diagnostics Market, by Application Type
      1. By Infectious Diseases
      2. By Oncology
      3. By Hematology
      4. By Prenatal Testing
      5. By Endocrinology
      6. By Other Applications
    5. Europe Point Of Care Molecular Diagnostics Market, by End-Use
      1. By Decentralized Labs
      2. By Hospitals
      3. By Home-care
      4. By Assisted Living Healthcare Facilities
      5. By Research Institutes
      6. By Other End Uses
    6. Europe Point Of Care Molecular Diagnostics Market, by Country
      1. Germany
        1. Germany Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. Germany Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. Germany Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      2. UK
        1. UK Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. UK Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. UK Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      3. France
        1. France Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. France Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. France Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      4. Spain
        1. Spain Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. Spain Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. Spain Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      5. Italy
        1. Italy Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. Italy Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. Italy Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      6. BENELUX
        1. BENELUX Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. BENELUX Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. BENELUX Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      7. Rest of Europe
        1. Rest Of Europe Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. Rest Of Europe Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. Rest Of Europe Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
  6. Asia Pacific Point Of Care Molecular Diagnostics Market - Segment Analysis
    1. Overview
    2. Asia Pacific Point Of Care Molecular Diagnostics Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Point Of Care Molecular Diagnostics Market, by Technology
      1. By Polymerase Chain Reaction (PCR)
      2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
      4. By DNA Sequencing
      5. By Microarrays
      6. By Other Technologies
    4. Asia Pacific Point Of Care Molecular Diagnostics Market, by Application Type
      1. By Infectious Diseases
      2. By Oncology
      3. By Hematology
      4. By Prenatal Testing
      5. By Endocrinology
      6. By Other Applications
    5. Asia Pacific Point Of Care Molecular Diagnostics Market, by End-Use
      1. By Decentralized Labs
      2. By Hospitals
      3. By Home-care
      4. By Assisted Living Healthcare Facilities
      5. By Research Institutes
      6. By Other End Uses
    6. Asia Pacific Point Of Care Molecular Diagnostics Market, by Country
      1. China
        1. China Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. China Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. China Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      2. Japan
        1. Japan Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. Japan Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. Japan Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      3. India
        1. India Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. India Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. India Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      4. South Korea
        1. South Korea Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. South Korea Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. South Korea Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      5. South East Asia
        1. South East Asia Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. South East Asia Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. South East Asia Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. Rest of Asia Pacific Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. Rest of Asia Pacific Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
  7. Latin America Point Of Care Molecular Diagnostics Market - Segment Analysis
    1. Overview
    2. Latin America Point Of Care Molecular Diagnostics Market, 2016 - 2028 (USD Million)
    3. Latin America Point Of Care Molecular Diagnostics Market, by Technology
      1. By Polymerase Chain Reaction (PCR)
      2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
      4. By DNA Sequencing
      5. By Microarrays
      6. By Other Technologies
    4. Latin America Point Of Care Molecular Diagnostics Market, by Application Type
      1. By Infectious Diseases
      2. By Oncology
      3. By Hematology
      4. By Prenatal Testing
      5. By Endocrinology
      6. By Other Applications
    5. Latin America Point Of Care Molecular Diagnostics Market, by End-Use
      1. By Decentralized Labs
      2. By Hospitals
      3. By Home-care
      4. By Assisted Living Healthcare Facilities
      5. By Research Institutes
      6. By Other End Uses
    6. Latin America Point Of Care Molecular Diagnostics Market, by Country
      1. Brazil
        1. Brazil Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. Brazil Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. Brazil Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      2. Argentina
        1. Argentina Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. Argentina Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. Argentina Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      3. Rest of Latin America
        1. Rest of Latin America Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. Rest of Latin America Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. Rest of Latin America Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
  8. Middle East & Africa Point Of Care Molecular Diagnostics Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Point Of Care Molecular Diagnostics Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Point Of Care Molecular Diagnostics Market, by Technology
      1. By Polymerase Chain Reaction (PCR)
      2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
      3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
      4. By DNA Sequencing
      5. By Microarrays
      6. By Other Technologies
    4. Middle East & Africa Point Of Care Molecular Diagnostics Market, by Application Type
      1. By Infectious Diseases
      2. By Oncology
      3. By Hematology
      4. By Prenatal Testing
      5. By Endocrinology
      6. By Other Applications
    5. Middle East & Africa Point Of Care Molecular Diagnostics Market, by End-Use
      1. By Decentralized Labs
      2. By Hospitals
      3. By Home-care
      4. By Assisted Living Healthcare Facilities
      5. By Research Institutes
      6. By Other End Uses
    6. Middle East & Africa Point Of Care Molecular Diagnostics Market, by Country
      1. GCC Countries
        1. GCC Countries Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. GCC Countries Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. GCC Countries Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      2. South Africa
        1. South Africa Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. South Africa Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. South Africa Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Point Of Care Molecular Diagnostics Market, By Technology
          1. By Polymerase Chain Reaction (PCR)
          2. By Isothermal Nucleic Acid Amplification Technology (INAAT)
          3. By Hybridization Technologies (Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
          4. By DNA Sequencing
          5. By Microarrays
          6. By Other Technologies
        2. Rest of Middle East & Africa Point Of Care Molecular Diagnostics Market, By Application Type
          1. By Infectious Diseases
          2. By Oncology
          3. By Hematology
          4. By Prenatal Testing
          5. By Endocrinology
          6. By Other Applications
        3. Rest of Middle East & Africa Point Of Care Molecular Diagnostics Market, By End-Use
          1. By Decentralized Labs
          2. By Hospitals
          3. By Home-care
          4. By Assisted Living Healthcare Facilities
          5. By Research Institutes
          6. By Other End Uses
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Abbott Laboratories (U.S.)
    2. Bayer AG (Germany)
    3. F. Hoffmann-La Roche AG (Switzerland)
    4. Nova Biomedical (U.S.)
    5. QIAGEN (Germany)
    6. Nipro Diagnostics (Japan)
    7. Danaher (U.S.)
    8. Bio-Rad Laboratories Inc. (U.S.)
    9. bioMérieux (France)
    10. Agilent Technologies Inc. (U.S.)
    11. Abaxis (U.S.)
    12. OraSure Technologies (U.S.)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question

  • The global Point Of Care Molecular Diagnostics valued at USD 4.1 Billion in 2022 and is expected to reach USD 8.2 Billion in 2030 growing at a CAGR of 9.1%.

  • The prominent players in the market are Abbott Laboratories (U.S.), Bayer AG (Germany), F. Hoffmann-La Roche AG (Switzerland), Nova Biomedical (U.S.), QIAGEN (Germany), Nipro Diagnostics (Japan), Danaher (U.S.), Bio-Rad Laboratories Inc. (U.S.), bioMérieux (France), Agilent Technologies Inc. (U.S.), Abaxis (U.S.), OraSure Technologies (U.S.).

  • The market is project to grow at a CAGR of 9.1% between 2023 and 2030.

  • The driving factors of the Point Of Care Molecular Diagnostics include

    • Increasing prevalence of Infectious diseases and cancer

  • North America was the leading regional segment of the Point Of Care Molecular Diagnostics in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy